What is the mechanism of action of insulin glargine in the management of type 1 diabetes mellitus?
Q92
A 14-year-old boy with type 1 diabetes for 6 years attends for his annual review. His HbA1c is 68 mmol/mol (8.4%). Screening blood tests reveal: total cholesterol 5.8 mmol/L, HDL 1.1 mmol/L, LDL 3.9 mmol/L, triglycerides 1.8 mmol/L, TSH 8.2 mU/L (normal 0.5-5.0), free T4 10 pmol/L (normal 10-20). He reports feeling tired but has no other symptoms. What is the most appropriate next step in management?
Q93
A 6-year-old boy with a history of febrile seizures at age 18 months presents with his first afebrile seizure. The episode lasted 20 seconds and consisted of right arm jerking followed by head turning to the right, with preserved awareness throughout. EEG shows focal epileptiform discharges in the left centrotemporal region. Brain MRI is normal. What is the most likely diagnosis?
Q94
A 9-year-old girl with type 1 diabetes mellitus presents to the diabetes clinic. She has been using a basal-bolus insulin regimen for 3 years. Her parents report that she frequently develops hypoglycaemia in the late afternoon after school sports. Blood glucose readings show values of 2.5-3.0 mmol/L at 4 PM on multiple occasions. Morning fasting glucose and pre-lunch readings are well controlled. Which adjustment to her insulin regimen is most appropriate?
Q95
A 8-year-old girl presents with episodes of sudden loss of muscle tone causing her to drop objects or fall to the ground. The episodes last 1-2 seconds, occur multiple times daily, and there is no loss of consciousness. She has mild learning difficulties. Her neurologist suspects Lennox-Gastaut syndrome. An EEG shows slow spike-wave complexes. Considering the specific seizure type and syndrome, which anti-epileptic medication would be most appropriate as first-line therapy?
Q96
A 15-year-old boy with type 1 diabetes for 8 years presents to clinic with concerns about his future. He asks about life expectancy and long-term outcomes. His HbA1c has averaged 58 mmol/mol over the past 5 years, he has no microvascular complications on screening, and he is generally adherent to treatment. His parents are present and supportive. What is the most appropriate response regarding long-term prognosis?
Q97
An 11-year-old boy with epilepsy controlled on carbamazepine is seen in clinic. His mother mentions that he has been experiencing double vision intermittently over the past month. Examination reveals horizontal diplopia on lateral gaze bilaterally. Serum carbamazepine level is reported as 14 mg/L (therapeutic range 4-12 mg/L). Full blood count and liver function tests are normal. Understanding the relationship between carbamazepine dosing and its side effects, what is the most appropriate management?
Q98
A 16-year-old girl with type 1 diabetes for 10 years attends for her annual complications screening. Retinal photography reveals several microaneurysms and small dot haemorrhages in both eyes but no cotton wool spots, venous changes, or new vessel formation. Visual acuity is 6/6 bilaterally and she is asymptomatic. Her HbA1c is 64 mmol/mol. What grade of diabetic retinopathy is present and what is the most appropriate management?
Q99
A 4-year-old boy presents to the emergency department with a first afebrile seizure lasting 3 minutes. It was generalized tonic-clonic in nature and self-terminated. He has now fully recovered with no neurological deficit. His development has been normal and there is no family history of epilepsy. Examination is unremarkable. What is the most appropriate initial management?
Q100
A 13-year-old girl with type 1 diabetes for 5 years presents to the diabetes clinic. She has recently started menstruating and her HbA1c has risen from 58 mmol/mol to 71 mmol/mol over the past 6 months despite no changes to her insulin regimen. She is on a basal-bolus regimen with insulin glargine once daily and insulin aspart with meals. Her mother reports she has been compliant with insulin administration. Blood glucose monitoring shows elevated readings particularly in the mornings and before lunch. What is the most likely explanation for her deteriorating glycaemic control?
Chronic Paediatric Conditions UK Medical PG Practice Questions and MCQs
Question 91: What is the mechanism of action of insulin glargine in the management of type 1 diabetes mellitus?
A. It stimulates endogenous insulin production from pancreatic beta cells
B. It increases peripheral glucose uptake and decreases hepatic glucose production (Correct Answer)
C. It delays gastric emptying and reduces postprandial glucose excursions
D. It inhibits renal glucose reabsorption leading to glycosuria
E. It enhances insulin receptor sensitivity in target tissues
Explanation: ***It increases peripheral glucose uptake and decreases hepatic glucose production***- Like all insulin molecules, **insulin glargine** binds to insulin receptors to facilitate **glucose transport** into muscle and adipose tissue.- It provides a steady **basal level** of insulin, which suppresses **gluconeogenesis** and glycogenolysis in the liver to maintain stable fasting blood glucose.*It stimulates endogenous insulin production from pancreatic beta cells*- This describes the mechanism of **sulfonylureas**; in **Type 1 Diabetes**, beta cells are destroyed, making this mechanism ineffective.- **Insulin glargine** is an exogenous replacement and does not produce native insulin from the pancreas.*It delays gastric emptying and reduces postprandial glucose excursions*- This is the mechanism associated with **GLP-1 receptor agonists** and **amylin analogs** (like pramlintide).- **Insulin glargine** is a long-acting basal insulin and is not primarily intended to manage sudden **postprandial spikes**.*It inhibits renal glucose reabsorption leading to glycosuria*- This mechanism is specific to **SGLT2 inhibitors** (gliflozins), which work in the **proximal convoluted tubule** of the kidney.- Insulin does not promote the excretion of glucose in urine; it promotes the **utilization and storage** of glucose.*It enhances insulin receptor sensitivity in target tissues*- This describes the action of **insulin sensitizers** such as **metformin** or thiazolidinediones (TZDs).- While insulin glargine binds to receptors, its primary effect is direct **metabolic signaling** rather than increasing the sensitivity of those receptors to existing insulin.
Question 92: A 14-year-old boy with type 1 diabetes for 6 years attends for his annual review. His HbA1c is 68 mmol/mol (8.4%). Screening blood tests reveal: total cholesterol 5.8 mmol/L, HDL 1.1 mmol/L, LDL 3.9 mmol/L, triglycerides 1.8 mmol/L, TSH 8.2 mU/L (normal 0.5-5.0), free T4 10 pmol/L (normal 10-20). He reports feeling tired but has no other symptoms. What is the most appropriate next step in management?
A. Start atorvastatin for dyslipidaemia
B. Start levothyroxine replacement therapy
C. Repeat thyroid function tests in 3 months
D. Check thyroid peroxidase antibodies and start levothyroxine if positive (Correct Answer)
E. Reassure and recheck thyroid function tests in 12 months
Explanation: ***Check thyroid peroxidase antibodies and start levothyroxine if positive***
- The patient has **type 1 diabetes**, a strong risk factor for **autoimmune thyroid disease** (Hashimoto's thyroiditis), and presents with **symptoms of fatigue** along with **elevated TSH** and **low-normal free T4**, indicating symptomatic subclinical hypothyroidism.
- Confirming the presence of **thyroid peroxidase (TPO) antibodies** will establish the autoimmune etiology, justifying the initiation of **levothyroxine replacement therapy** to alleviate symptoms and prevent progression to overt hypothyroidism.
*Start atorvastatin for dyslipidaemia*
- The patient's **dyslipidaemia** could be secondary to both **poor glycemic control** (HbA1c 8.4%) and the newly identified **subclinical hypothyroidism**.
- It is more appropriate to first optimize **glycemic control** and treat the **hypothyroidism**, as these interventions may resolve the dyslipidaemia, reducing the need for **statin therapy** in a young patient.
*Start levothyroxine replacement therapy*
- While treatment with **levothyroxine** is likely indicated given the symptoms and lab results, it is best practice to first confirm the **autoimmune nature** of the thyroid dysfunction.
- Testing for **TPO antibodies** before initiating lifelong therapy provides a more complete diagnosis and helps guide long-term management decisions, particularly in patients with **type 1 diabetes**.
*Repeat thyroid function tests in 3 months*
- This patient is **symptomatic** (fatigue) and has **type 1 diabetes**, putting him at high risk for autoimmune thyroiditis, making a watchful waiting approach inappropriate.
- Delaying further investigation for 3 months would postpone a definitive diagnosis and the potential benefits of early treatment for his **subclinical hypothyroidism**.
*Reassure and recheck thyroid function tests in 12 months*
- **Reassurance** is not appropriate as the patient is experiencing **fatigue** and has clear biochemical evidence of **thyroid dysfunction** (elevated TSH, low-normal free T4).
- Waiting **12 months** for a recheck is too long; his symptoms and test results warrant more immediate investigation and potential management, especially given his underlying **type 1 diabetes**.
Question 93: A 6-year-old boy with a history of febrile seizures at age 18 months presents with his first afebrile seizure. The episode lasted 20 seconds and consisted of right arm jerking followed by head turning to the right, with preserved awareness throughout. EEG shows focal epileptiform discharges in the left centrotemporal region. Brain MRI is normal. What is the most likely diagnosis?
A. Juvenile myoclonic epilepsy
B. Benign epilepsy with centrotemporal spikes (BECTS) (Correct Answer)
C. Childhood absence epilepsy
D. Temporal lobe epilepsy
E. Lennox-Gastaut syndrome
Explanation: ***Benign epilepsy with centrotemporal spikes (BECTS)***
- The clinical presentation of a school-aged child with focal motor seizures (right arm jerking, head turning) and **preserved awareness** is classic for BECTS, also known as **Benign Rolandic Epilepsy**.
- The diagnosis is confirmed by the characteristic EEG finding of **centrotemporal spikes** and a **normal brain MRI**, with an excellent prognosis for remission by adolescence.
*Juvenile myoclonic epilepsy*
- This syndrome typically presents later in **adolescence** (ages 12-18) with a triad of **myoclonic jerks**, generalized tonic-clonic seizures, and absence seizures.
- The EEG in JME shows **generalized 4-6 Hz polyspike-and-wave** discharges rather than focal centrotemporal spikes.
*Childhood absence epilepsy*
- Characterized by brief **staring spells** with sudden impairment of consciousness, usually lasting only seconds without a postictal state.
- The diagnostic hallmark on EEG is a **generalized 3-Hz spike-and-wave** pattern, which differs from the focal discharges seen in this patient.
*Temporal lobe epilepsy*
- Often involves **impaired awareness** (complex partial seizures) and is frequently associated with **automatisms** (e.g., lip-smacking) or an aura.
- While it can cause focal discharges, it is more likely to show abnormalities on **brain MRI** (such as hippocampal sclerosis) and has a less favorable prognosis than BECTS.
*Lennox-Gastaut syndrome*
- This is a severe childhood epilepsy characterized by **multiple seizure types** (atonic, tonic, atypical absence) and **intellectual disability**.
- The EEG typically shows a **slow spike-wave pattern** (<2.5 Hz) and the condition is associated with significant developmental delay.
Question 94: A 9-year-old girl with type 1 diabetes mellitus presents to the diabetes clinic. She has been using a basal-bolus insulin regimen for 3 years. Her parents report that she frequently develops hypoglycaemia in the late afternoon after school sports. Blood glucose readings show values of 2.5-3.0 mmol/L at 4 PM on multiple occasions. Morning fasting glucose and pre-lunch readings are well controlled. Which adjustment to her insulin regimen is most appropriate?
A. Increase the morning rapid-acting insulin dose
B. Reduce the morning long-acting insulin dose (Correct Answer)
C. Increase the lunchtime rapid-acting insulin dose
D. Reduce the evening long-acting insulin dose
E. Add an additional snack before breakfast
Explanation: ***Reduce the morning long-acting insulin dose***
- Late afternoon **hypoglycaemia** (4 PM) following physical activity suggests that the **basal insulin** levels are too high during the period of increased insulin sensitivity induced by exercise.
- Reducing the **morning long-acting insulin** (e.g., Glargine or Detemir) lowers the background insulin concentration specifically during the day, preventing drops when activity levels are highest.
*Increase the morning rapid-acting insulin dose*
- This would lead to **hypoglycaemia** before or during lunch, as the peak action of **bolus insulin** occurs 1–3 hours after administration.
- It does not address the late afternoon issue and would likely worsen the patient's overall **glycaemic control** by causing earlier lows.
*Increase the lunchtime rapid-acting insulin dose*
- Increasing the **prandial dose** at lunch would cause significant **hypoglycaemia** in the immediate post-prandial period (1–3 hours after lunch).
- It would exacerbate the existing low glucose readings at 4 PM rather than preventing them.
*Reduce the evening long-acting insulin dose*
- The **evening basal insulin** dose primarily regulates hepatic glucose production **overnight** and determines the **fasting morning glucose**.
- Since the morning fasting readings are already well controlled, reducing this dose might lead to **hyperglycaemia** upon waking.
*Add an additional snack before breakfast*
- A snack before breakfast would be ineffective for **hypoglycaemia** occurring in the late afternoon, as the caloric intake would be metabolized long before the 4 PM drop.
- While a **pre-exercise snack** might help, the medical adjustment focus should be on addressing the excessive **basal insulin** dose relative to the child's activity level.
Question 95: A 8-year-old girl presents with episodes of sudden loss of muscle tone causing her to drop objects or fall to the ground. The episodes last 1-2 seconds, occur multiple times daily, and there is no loss of consciousness. She has mild learning difficulties. Her neurologist suspects Lennox-Gastaut syndrome. An EEG shows slow spike-wave complexes. Considering the specific seizure type and syndrome, which anti-epileptic medication would be most appropriate as first-line therapy?
A. Carbamazepine
B. Sodium valproate (Correct Answer)
C. Ethosuximide
D. Phenytoin
E. Gabapentin
Explanation: ***Sodium valproate***
- **Sodium valproate** is the broad-spectrum first-line treatment for **Lennox-Gastaut syndrome** as it effectively targets multiple seizure types including **atonic (drop attacks)**, tonic, and atypical absence seizures.
- It is the preferred initial choice for generalized epilepsy syndromes with a multi-focal nature and characteristic **slow spike-wave EEG** patterns.
*Carbamazepine*
- Primarily used for focal seizures, **carbamazepine** is known to **exacerbate** atonic, myoclonic, and absence seizures.
- It is generally contraindicated in cases of **Lennox-Gastaut syndrome** as it can worsen the frequency of drop attacks.
*Ethosuximide*
- This medication is the gold standard for **typical absence seizures** but lacks efficacy in managing **atonic** or tonic seizures.
- It does not address the broad range of seizure semiologies found in **Lennox-Gastaut syndrome**.
*Phenytoin*
- Similar to carbamazepine, **phenytoin** can aggravate certain generalized seizure types and is not a first-line agent for complex pediatric epilepsy syndromes.
- Its side effect profile and narrow therapeutic window make it unsuitable for the long-term management of **childhood encephalopathic epilepsies**.
*Gabapentin*
- **Gabapentin** has a narrow spectrum of activity focused on focal seizures and is largely **ineffective** for the generalized seizures seen in this patient.
- It is not recommended for the treatment of **Lennox-Gastaut syndrome** or typical **drop attacks**.
Question 96: A 15-year-old boy with type 1 diabetes for 8 years presents to clinic with concerns about his future. He asks about life expectancy and long-term outcomes. His HbA1c has averaged 58 mmol/mol over the past 5 years, he has no microvascular complications on screening, and he is generally adherent to treatment. His parents are present and supportive. What is the most appropriate response regarding long-term prognosis?
A. Life expectancy is significantly reduced regardless of glycaemic control
B. With good glycaemic control from an early age, life expectancy approaches that of the general population (Correct Answer)
C. Life expectancy is normal but quality of life is substantially impaired by complications
D. Prognosis discussion should be deferred until after transition to adult services
E. Outcomes are unpredictable and discussing prognosis is not helpful
Explanation: ***With good glycaemic control from an early age, life expectancy approaches that of the general population***
- Evidence from major trials like **DCCT/EDIC** shows that intensive **glycaemic control** (HbA1c <58 mmol/mol) significantly reduces the risk of **microvascular** and **macrovascular** complications.
- Maintaining excellent control from a young age can close the gap in mortality, allowing patients to have a life expectancy nearly equal to those without **Type 1 Diabetes**.
*Life expectancy is significantly reduced regardless of glycaemic control*
- This statement is outdated and overly pessimistic, failing to account for modern **insulin analogues** and **continuous glucose monitoring**.
- Modern management focuses on the fact that clinical outcomes and longevity are directly correlated with **metabolic control**.
*Life expectancy is normal but quality of life is substantially impaired by complications*
- **Complications** such as retinopathy or nephropathy are not inevitable if **glycaemic targets** and **blood pressure** are consistently managed.
- Many patients with well-controlled diabetes lead highly active, high-quality lives without significant **morbidity** from long-term sequelae.
*Prognosis discussion should be deferred until after transition to adult services*
- High-quality diabetes care requires **open communication** and **empowerment** of the adolescent during the transition phase.
- Delaying these discussions can lead to **anxiety** and disengagement from treatment at a time when the patient is taking more personal responsibility.
*Outcomes are unpredictable and discussing prognosis is not helpful*
- Prognosis is largely predictable based on **long-term glycaemic trends** and the presence or absence of early **microalbuminuria**.
- Providing positive, evidence-based prognostic information serves as a powerful **motivator** for treatment adherence and self-care.
Question 97: An 11-year-old boy with epilepsy controlled on carbamazepine is seen in clinic. His mother mentions that he has been experiencing double vision intermittently over the past month. Examination reveals horizontal diplopia on lateral gaze bilaterally. Serum carbamazepine level is reported as 14 mg/L (therapeutic range 4-12 mg/L). Full blood count and liver function tests are normal. Understanding the relationship between carbamazepine dosing and its side effects, what is the most appropriate management?
A. Reduce carbamazepine dose and monitor symptoms (Correct Answer)
B. Continue current dose as diplopia often resolves spontaneously
C. Switch immediately to sodium valproate
D. Arrange urgent MRI brain to exclude structural pathology
E. Add pyridoxine supplementation to reduce toxicity
Explanation: ***Reduce carbamazepine dose and monitor symptoms*** - The patient presents with **diplopia** and a serum level of **14 mg/L**, which exceeds the standard **therapeutic range (4-12 mg/L)**, indicating dose-dependent neurotoxicity.- Reducing the dose is the most logical next step to resolve symptoms like **nystagmus**, **ataxia**, and **diplopia** while maintaining the drug's antiepileptic efficacy.*Continue current dose as diplopia often resolves spontaneously*- Dose-dependent side effects of **carbamazepine** do not typically resolve spontaneously if the serum concentration remains in the **toxic range**.- Maintaining the current dose risks further toxicity and persistent neurological symptoms that can interfere with daily activities.*Switch immediately to sodium valproate*- Switching medications is unnecessary when seizures are well-controlled and the side effects are **dose-related** rather than an **idiosyncratic reaction** (like a severe rash).- A rapid switch also carries risks of **seizure breakthrough** or adverse reactions to the new agent before attempting a simple dose adjustment.*Arrange urgent MRI brain to exclude structural pathology*- While new neurological symptoms can warrant imaging, the **temporal relationship** with elevated drug levels makes medication toxicity the most likely cause.- An **MRI brain** should only be considered if symptoms persist after the serum carbamazepine level has been returned to the **therapeutic range**.*Add pyridoxine supplementation to reduce toxicity*- **Pyridoxine (Vitamin B6)** supplementation has no clinical role in managing or reversing **carbamazepine toxicity**.- It is primarily used to prevent peripheral neuropathy associated with **isoniazid** or in specific cases of neonatal **pyridoxine-dependent epilepsy**.
Question 98: A 16-year-old girl with type 1 diabetes for 10 years attends for her annual complications screening. Retinal photography reveals several microaneurysms and small dot haemorrhages in both eyes but no cotton wool spots, venous changes, or new vessel formation. Visual acuity is 6/6 bilaterally and she is asymptomatic. Her HbA1c is 64 mmol/mol. What grade of diabetic retinopathy is present and what is the most appropriate management?
A. Background retinopathy; continue annual screening
B. Pre-proliferative retinopathy; refer to ophthalmology within 2 weeks
C. Mild non-proliferative retinopathy; arrange ophthalmology review within 13 weeks (Correct Answer)
D. Background retinopathy; arrange ophthalmology review within 6 weeks
E. Maculopathy; refer urgently to ophthalmology
Explanation: ***Mild non-proliferative retinopathy; arrange ophthalmology review within 13 weeks***
- This patient exhibits **microaneurysms** and **dot hemorrhages**, which are the hallmark features of **mild non-proliferative retinopathy** (formerly known as background retinopathy).
- According to current guidelines for pediatrics and adults, the presence of these changes requires a routine **ophthalmology referral** typically completed within **13 weeks** to monitor for progression.
*Background retinopathy; continue annual screening*
- Annual screening is only appropriate if there is **no retinopathy** (R0) detected during the photography session.
- Once **microaneurysms** or hemorrhages are present, the patient must be moved from screening into an **ophthalmology review** pathway.
*Pre-proliferative retinopathy; refer to ophthalmology within 2 weeks*
- **Pre-proliferative retinopathy** is characterized by more severe features such as **cotton wool spots**, **venous beading**, or intraretinal microvascular abnormalities (IRMA).
- This patient lacks these high-risk features and **asymptomatic 6/6 vision**, making a 2-week urgent referral unnecessary at this stage.
*Background retinopathy; arrange ophthalmology review within 6 weeks*
- While the features described match the definition of **background retinopathy**, a **6-week timeframe** is generally reserved for more concerning findings or specific monitoring protocols.
- Routine follow-up for mild, non-sight-threatening changes is standardized to the **13-week** window in most referral pathways.
*Maculopathy; refer urgently to ophthalmology*
- **Maculopathy** is diagnosed when there are **hard exudates**, hemorrhages, or thickening within one disc diameter of the **fovea**.
- There is no evidence of macular involvement or **reduced visual acuity** in this patient to justify an urgent referral for maculopathy.
Question 99: A 4-year-old boy presents to the emergency department with a first afebrile seizure lasting 3 minutes. It was generalized tonic-clonic in nature and self-terminated. He has now fully recovered with no neurological deficit. His development has been normal and there is no family history of epilepsy. Examination is unremarkable. What is the most appropriate initial management?
A. Arrange urgent MRI brain and EEG, discharge with safety advice (Correct Answer)
B. Commence levetiracetam and arrange outpatient neurology review
C. Arrange routine paediatric neurology outpatient appointment
D. Admit for 24-hour observation and commence anti-epileptic medication
E. Perform lumbar puncture to exclude CNS infection
Explanation: ***Arrange urgent MRI brain and EEG, discharge with safety advice***
- In a child with a **first afebrile seizure** that has self-terminated and led to full recovery, it is crucial to arrange **urgent investigations** like an **MRI brain** to rule out structural causes and an **EEG** to assess the risk of recurrence and identify potential epilepsy syndromes.
- Given the child has fully recovered with no neurological deficits and normal development, discharge with clear **safety advice** (e.g., avoiding unsupervised swimming, bathing, or climbing) is appropriate while awaiting specialist review and investigation results.
*Commence levetiracetam and arrange outpatient neurology review*
- **Anti-epileptic drugs (AEDs)** are generally not initiated after a single unprovoked seizure, especially in a child with no high-risk features for recurrence, as many children will not have another seizure.
- Starting **levetiracetam** prophylactically would expose the child to potential side effects without a clear benefit at this initial stage.
*Arrange routine paediatric neurology outpatient appointment*
- While follow-up with neurology is necessary, a **routine outpatient appointment** is insufficient as the initial management for a first unprovoked seizure.
- **Urgent investigations** (EEG, MRI) are typically recommended to identify the cause and risk factors promptly, which might be delayed by a routine appointment.
*Admit for 24-hour observation and commence anti-epileptic medication*
- Admission for **24-hour observation** is not usually indicated for a child who has fully recovered from a brief, self-terminated seizure and has no ongoing neurological compromise.
- Commencing **anti-epileptic medication** after a single unprovoked seizure is generally not recommended unless there are clear indications for high recurrence risk, which are absent here.
*Perform lumbar puncture to exclude CNS infection*
- A **lumbar puncture** is not indicated in this case because the child is **afebrile**, has no signs of meningism (e.g., neck stiffness, photophobia), and has returned to baseline neurological function.
- There are no clinical features suggestive of a **central nervous system infection** (meningitis or encephalitis) that would warrant an invasive procedure.
Question 100: A 13-year-old girl with type 1 diabetes for 5 years presents to the diabetes clinic. She has recently started menstruating and her HbA1c has risen from 58 mmol/mol to 71 mmol/mol over the past 6 months despite no changes to her insulin regimen. She is on a basal-bolus regimen with insulin glargine once daily and insulin aspart with meals. Her mother reports she has been compliant with insulin administration. Blood glucose monitoring shows elevated readings particularly in the mornings and before lunch. What is the most likely explanation for her deteriorating glycaemic control?
A. Reduced physical activity due to menstruation
B. Surreptitious consumption of high-carbohydrate foods
C. Insulin resistance associated with puberty and increased sex hormone production (Correct Answer)
D. Development of insulin antibodies reducing insulin efficacy
E. Gastroparesis causing erratic carbohydrate absorption
Explanation: ***Insulin resistance associated with puberty and increased sex hormone production***- During **puberty**, surges in **growth hormone** and **sex hormones** (estrogen, progesterone) lead to significant physiological **insulin resistance**, often requiring a substantial increase in insulin doses.- The recent onset of **menstruation** (menarche) is a clear indicator of puberty, directly correlating with the 6-month rise in **HbA1c** and consistent elevated morning and pre-lunch glucose readings despite reported compliance.*Reduced physical activity due to menstruation*- While physical activity impacts glucose, a temporary reduction during menstruation would typically not cause such a sustained and significant 6-month rise in **HbA1c** (from 58 to 71 mmol/mol).- The deterioration is more consistently explained by **hormonal shifts** associated with puberty rather than a minor, intermittent lifestyle change.*Surreptitious consumption of high-carbohydrate foods*- Although dietary non-compliance can lead to hyperglycemia, the clinical picture strongly points to the recent onset of **puberty** and **menstruation** as the primary triggers for deteriorating control.- The pattern of consistently **elevated morning** and pre-lunch readings is more characteristic of physiological insulin resistance rather than random surreptitious eating.*Development of insulin antibodies reducing insulin efficacy*- The development of **insulin antibodies** is exceedingly rare with modern **recombinant human insulin analogs** like glargine and aspart, which are engineered to minimize immunogenicity.- If present, it would typically result in more unpredictable and severe glucose fluctuations, not a steady upward trend synchronized with **pubertal milestones**.*Gastroparesis causing erratic carbohydrate absorption*- **Diabetic gastroparesis** is a severe, late complication of long-standing, poorly controlled diabetes and is highly improbable in a 13-year-old with only a 5-year history of type 1 diabetes.- Gastroparesis typically causes **delayed gastric emptying**, leading to erratic glucose levels and often **postprandial hypoglycemia** due to mismatched insulin action, not consistent morning and pre-lunch hyperglycemia.
